Physician profile
Fred Rahimi
NPI 1588661110
$2,831.01
in general payments reported to CMS, 2019-2025
28 companies · $591 in 2025
The $591 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $269 · 2020: $653 · 2021: $82.73 · 2022: $234 · 2023: $193 · 2024: $808 · 2025: $591.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,392 · Consulting Fee: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,392.00 |
| Consulting Fee | $200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medwest Associates | $673.79 | 2020-2022 | |
| Treace Medical Concepts, INC. | $545.49 | 2023-2025 | |
| Stryker Corporation | $335.05 | 2021-2025 | Ortholoc 2 Lapifuse, T2, Hoffmann |
| Fusion Orthopedics USA, LLC | $210.93 | 2024-2025 | |
| Globus Medical, INC. | $210.36 | 2025 | Senza |
| Melinta Therapeutics, LLC | $96.14 | 2019-2021 | |
| Paragon 28, INC. | $94.70 | 2024-2025 | Bun-Yo-Matic, Activcore Nail, Plating Portfolio |
| Abbott Laboratories | $87.68 | 2022-2024 | Proclaim, Eterna |
| Depuy Synthes Sales INC. | $77.62 | 2019-2024 | Motoband, Minibunion |
| Orthofix Medical, INC. | $52.87 | 2023-2025 | Physio-Stim |
| Kerecis Limited | $48.68 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Encore Medical, Lp | $44.75 | 2022 | |
| Smith+Nephew, INC. | $44.44 | 2023 | Grafix Pl |
| Misonix INC | $28.87 | 2019 | |
| Nalu Medical, INC. | $28.15 | 2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medline Industries Lp | $27.33 | 2019 | |
| Wright Medical Technology, INC. | $24.55 | 2019 | |
| Abbvie INC. | $23.92 | 2021 | |
| Axogen | $21.17 | 2022 | |
| Normatec Industries, Lp | $21.01 | 2019 | |
| Amgen INC. | $20.37 | 2024 | Krystexxa |
| Integra Lifesciences Corporation | $19.77 | 2019 | |
| Horizon Therapeutics Plc | $18.60 | 2023 | Krystexxa |
| Acumed LLC | $17.71 | 2025 | Acumed, Osteomed |
| Osteomed LLC | $16.46 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $15.16 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $13.20 | 2019 | |
| Merck Sharp & Dohme LLC | $12.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fred Rahimi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.